ArticleThe Lancet. Neurology2021

Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study.

Anne M Fagan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.